Abstract Library

#4108 Clinical and epidemiological profile of neuroendocrine differentiation – A hospital-based retrospective study

Introduction: Global research on neuroendocrine differentiation (NED) in carcinomas remains limited, despite its distinct clinical features, disease progression, pathology, treatment outcomes, and poor prognosis. At the 2023 ENETS Conference, we presented our findings on NED in gastric cancer and colorectal cancer. However, more studies are essential to better comprehend NED's clinical and epidemiological aspects.

Conference:

Presenting Author:

Authors: Wen Y, Shi S,

Keywords: Neuroendocrine differentiation, breast cancer, lung cancer, esophageal cancer, prostate cancer,

#3806 Epidemiologic study of neuroendocrine differentiation in different carcinomas

Introduction: Carcinomas with neuroendocrine differentiation (NED) are characterized by clinical manifestations, pathological changes, treatment responses and poor prognosis. But there are few studies around the world currently. Further analysis of large clinical samples is still needed to reveal its biological characteristics and clarify the diagnosis and treatment of NED.

Conference:

Presenting Author:

Authors: Wen Y, Shi S,

Keywords: Neuroendocrine differentiation, individualized treatment, colorectal cancer, gastric cancer,

#3406 Neoadjuvant treatment in locally advanced pancreatic neuroendocrine tumor G3

Introduction: Bordeline or locally advanced pancreatic neuroendocrine tumors are potentially resectable in selected cases. The role of neoadjuvant chemotherapy has not been established, and there are published only few small studies dealing with this issue.

Conference:

Presenting Author: Pindura M

Authors: Pindura M, Kyčina R, Palkoci B, Nosakova L, Uhrík P,

Keywords: pancreatic neuroendocrine tumor, neoadjuvant treatment, surgery, locally advanced neuroendocrine pancreatic tumor,

#3076 Endometrial Small Cell Neuroendocrine Carcinoma: Case Report and Literature Review

Introduction: Endometrial small-cell neuroendocrine carcinoma (ESCNEC) is extremely rare. It is characterized by early regional and systemic spread leading to rapid development of lymph nodes, pelvic and extrapelvic metastasis and compromising the outcome.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Aris H, Ghomari S,

Keywords: endometrial small cell neuroendocrine carcinoma, surgery, adjuvant chemotherapy, brachytherapy,

#2298 Large Cell Neuroendocrine Carcinoma of the Lung with Atypical Evolution and Great Response to Innovative Treatments

Introduction: Pulmonary neuroendocrine tumors are a group of heterogeneous neoplasms that represent 1% to 2% of all lung cancers.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Escala Cornejo R

Authors: Escala Cornejo R, Navarro M, García-Talavera SanMiguel P, Pérez López B, García Muñoz M,

Keywords: LCNEC,